DOI QR코드

DOI QR Code

Establishment of Reference Values for Non-HLA Antibodies in Patients With End-stage Renal Disease

  • Kyung-Hwa Shin (Department of Laboratory Medicine, Pusan National University School of Medicine) ;
  • Hyun Ji Lee (Department of Laboratory Medicine, Pusan National University School of Medicine) ;
  • Young Kim (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Byung Hyun Choi (Department of Surgery, Pusan National University Yangsan Hospital) ;
  • Hyung-Hoi Kim (Biomedical Research Institute, Pusan National University Hospital)
  • Received : 2022.07.07
  • Accepted : 2022.09.15
  • Published : 2023.03.01

Abstract

Keywords

Acknowledgement

This study was supported by a National Research Foundation of Korea Grant funded by the Korean Government (grant No. NRF-2019R1C1C10073788) and a Pusan National University Research Grant, 2021.

References

  1. Kamburova EG, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, et al. Development and validation of a multiplex nonHLA antibody assay for the screening of kidney transplant recipients. Front Immunol 2018;9:3002. https://doi.org/10.3389/fimmu.2018.03002
  2. Kamburova EG, Gruijters ML, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, et al. Antibodies against ARHGDIB are associated with long‐ term kidney graft loss. Am J Transplant 2019;19:3335-44. https://doi.org/10.1111/ajt.15493
  3. Rampersad C, Shaw J, Gibson IW, Wiebe C, Rush DN, Nickerson PW, et al. Early antibody-mediated kidney transplant rejection associated with anti-vimentin antibodies: a case report. Am J Kidney Dis 2020;75: 138-43. https://doi.org/10.1053/j.ajkd.2019.06.010
  4. Kang H, Yoo J, Lee SY, Oh EJ. Causes of positive pretransplant crossmatches in the absence of donor-specific anti-human leukocyte antigen antibodies: a single-center experience. Ann Lab Med 2021;41:429-35. https://doi.org/10.3343/alm.2021.41.4.429
  5. Miura K, Shirai Y, Kaneko N, Yabuuchi T, Ishizuka K, Horita S, et al. Chronic active antibody-mediated rejection with linear IgG deposition on glomerular capillaries in a kidney transplant recipient. Nephron 2020; 144(Sl) 1:97-101. https://doi.org/10.1159/000511322
  6. Riesco L, Irure J, Rodrigo E, Guiral S, Ruiz JC, Gómez J, et al. Anti-perlecan antibodies and acute humoral rejection in hypersensitized patients without forbidden HLA specificities after kidney transplantation. Transpl Immunol 2019;52:53-6. https://doi.org/10.1016/j.trim.2018.11.002
  7. Rotondi M, Netti GS, Lazzeri E, Stallone G, Bertoni E, Chiovato L, et al. High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients. Transpl Int 2010;23:465-75. https://doi.org/10.1111/j.1432-2277.2009.01006.x
  8. Zhang X and Reinsmoen NL. Impact of non-human leukocyte antigenspecific antibodies in kidney and heart transplantation. Front Immunol 2017;8:434. https://doi.org/10.3389/fimmu.2017.00434
  9. Cardinal H, Dieudé, M, Hébert, MJ. The emerging importance of nonHLA autoantibodies in kidney transplant complications. J Am Soc Nephrol 2017;28:400-6. https://doi.org/10.1681/ASN.2016070756